Fintel reports that on June 30, 2023, B of A Securities initiated coverage of U.S. Physical Therapy (NYSE:USPH) with a Buy recommendation. Analyst Price Forecast Suggests 3.29% Upside As of June 2, 2023, the average one-year price target for U.S. Physical Therapy is 121.04. The forecasts range from a low of 116.15 to a high...
Month: June 2023
Escrow Is Probably Why Your Housing Payment Increased
The last few years saw a rash of home-buying due to low interest rates and the pandemic. That’s great. But what I’m seeing and hearing more and more now from new homeowners who’ve been in their houses for a year or two is this: “I thought my mortgage payment was fixed, but I just got...
The Earnings Picture Refuses to Weaken
There is no shortage of market skeptics who see this year’s gains as without a fundamental basis and support. The skeptics justifiably point to the market’s narrow leadership in the mega-cap Tech players as a major argument why they don’t see the rally having sustainable legs. This is a fair point, though it’s important to...
China’s WORK Medical upsizes proposed US IPO to $14M (Pending:WOK)
Ingenious Buddy China’s WORK Medical Technology Group (WOK) has upsized its proposed US initial public offering to $14M. The medical products provider said that it is looking to offer 3M shares priced between $4 and $5, which would raise nearly $14M if priced at the midpoint. WORK Medical hopes to list its shares on Nasdaq...
BNSF Railway wins new trial over $228 million jury award in biometric data case By Reuters
© Reuters. FILE PHOTO: Spare train wheels are stored at a Burlington Northern Santa Fe (BNSF) railyard in Seattle, Washington, U.S., February 10, 2017. REUTERS/Chris Helgren/File Photo By Mike Scarcella (Reuters) – A U.S. judge on Friday ordered a new trial on damages against BNSF Railway in a privacy class action, in a ruling that...
Eleison Pharmaceuticals scraps plans for proposed $40M IPO
Chunumunu Eleison Pharmaceuticals (ESLN) has withdrawn its registration for a proposed $40M initial public offering. The oncology drug developer first filed for the IPO in January 2022. Based in New Jersey, Eleison’s lead drug candidate, glufosfamide, is in Phase 3 development for the treatment of pancreatic cancer. The company also has two compounds entering Phase...
Powerful 2-Timeframe Setup | Stock Talk with Joe Rabil
On this week’s edition of Stock Talk with Joe Rabil, Joe shows the criteria he is looking for when trading 2 timeframes. He covers the MA setup on both timeframes, price setup, and the preferred momentum conditions to this approach. This approach can be used in any 2 timeframes. Joe then analyses the symbols requests...
RBC Capital Reiterates Catalent (CTLT) Outperform Recommendation
Fintel reports that on June 30, 2023, RBC Capital reiterated coverage of Catalent (NYSE:CTLT) with a Outperform recommendation. Analyst Price Forecast Suggests 19.50% Upside As of June 2, 2023, the average one-year price target for Catalent is 48.20. The forecasts range from a low of 28.28 to a high of $90.30. The average price target...
Mexican REIT Vesta IPO prices, bringing gross proceeds to $388M (Pending:VTMX)
AndreyPopov Corporación Inmobiliaria Vesta (VTMX), a REIT that specializes in industrial properties in Mexico, said its initial public offering of 12.5M American Depositary Shares, priced late Thursday at $31.00 per ADS, amounting to gross proceeds of $387.5M. The ADSs represent 125M of the REIT’s common shares. The offering is expected to settle on or about...
India stocks higher at close of trade; Nifty 50 up 1.14% By Investing.com
© Reuters India stocks higher at close of trade; Nifty 50 up 1.14% Investing.com – India stocks were higher after the close on Friday, as gains in the , and sectors led shares higher. At the close in NSE, the gained 1.14% to hit a new all time high, while the index added 1.26%. The...